Salima Hacein-Bey-Abina Selected Research

Salima Hacein-Bey-Abina Research Topics

Disease

6	X-Linked Combined Immunodeficiency Diseases (X Linked Severe Combined Immunodeficiency) 10/2014 - 04/2002
4	Demyelinating Diseases (Demyelinating Disease) 10/2021 - 11/2009
4	Autoimmune Diseases (Autoimmune Disease) 03/2021 - 10/2018
3	Neoplasms (Cancer) 01/2022 - 07/2002
3	Rheumatoid Arthritis 01/2019 - 01/2018
3	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 06/2015 - 11/2002
3	Leukemia 10/2014 - 07/2010
3	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 01/2012 - 11/2009
3	Graft vs Host Disease (Graft-Versus-Host Disease) 09/2010 - 01/2002
2	Severe combined immunodeficiency due to adenosine deaminase deficiency 01/2020 - 10/2012
2	Bronchiolitis Obliterans Syndrome 10/2009 - 04/2009
1	Stroke (Strokes) 08/2021
1	Vasculitis (Vasculitides) 03/2021
1	Necrosis 01/2021
1	Lymphoma (Lymphomas) 01/2021
1	Polyneuropathies (Polyneuropathy) 01/2021
1	Arthritis (Polyarthritis) 01/2021
1	Multiple Sclerosis 01/2021
1	Joint Diseases (Joint Disease) 01/2021
1	Thrombosis (Thrombus) 01/2020
1	Thrombocytopenia (Thrombopenia) 01/2020
1	Severe combined immunodeficiency with sensitivity to ionizing radiation 12/2019
1	Sialadenitis 01/2019
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2019
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2019
1	Thalassemia 01/2018
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2017
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2017
1	Papillomavirus Infections 04/2009
1	Infections 04/2009
1	T-Cell Leukemia (Leukemia, T Cell) 09/2008
1	Opportunistic Infections (Opportunistic Infection) 07/2002
1	Hematologic Neoplasms (Hematological Malignancy) 01/2002

Drug/Important Bio-Agent (IBA)

7	AntibodiesIBA 08/2021 - 01/2018
6	Pharmaceutical PreparationsIBA 01/2020 - 01/2018
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 11/2009
3	Adenosine Triphosphate (ATP)IBA 01/2012 - 11/2009
2	Chimeric Antigen ReceptorsIBA 01/2022 - 11/2020
2	Adenosine DeaminaseIBA 01/2020 - 10/2012
2	Adalimumab (Humira)FDA Link 01/2019 - 01/2018
2	GlobinsIBA 01/2018 - 01/2017
2	Interleukin-2 Receptors (IL 2 Receptor)IBA 10/2014 - 09/2008
2	HLA Antigens (Human Leukocyte Antigens)IBA 09/2010 - 10/2009
1	Dihydrotachysterol (AT 10)IBA 10/2021
1	GadoliniumIBA 10/2021
1	SS-A antibodiesIBA 08/2021
1	Rituximab (Mabthera)FDA Link 03/2021
1	obinutuzumabIBA 03/2021
1	larazotide acetateIBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	AutoantigensIBA 01/2021
1	InterleukinsIBA 01/2021
1	claudin 8IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Messenger RNA (mRNA)IBA 12/2019
1	Etanercept (Enbrel)FDA Link 01/2019
1	Infliximab (Remicade)FDA Link 01/2019
1	anti-dsDNA autoantibodyIBA 01/2019
1	Tumor Necrosis Factor InhibitorsIBA 10/2018
1	Adenosine (Adenocard)FDA LinkGeneric 10/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Hemoglobins (Hemoglobin)IBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Cytidine DeaminaseIBA 09/2017
1	Sickle HemoglobinIBA 01/2017
1	Complementary DNA (cDNA)IBA 10/2014
1	ElementsIBA 06/2011
1	Interleukin Receptor Common gamma SubunitIBA 07/2010
1	Immunoglobulins (Immunoglobulin)IBA 07/2010
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 02/2010
1	AntigensIBA 07/2002
1	Interleukin-2 Receptor alpha SubunitIBA 07/2002
1	Immunotoxins (Immunotoxin)IBA 07/2002

Therapy/Procedure

9	Therapeutics 01/2021 - 11/2002
4	Stem Cell Transplantation 09/2010 - 01/2002
3	Transplantation 01/2018 - 01/2002
2	Hematopoietic Stem Cell Transplantation 04/2009 - 01/2002
1	Immunotherapy 01/2022
1	Biological Therapy 01/2020
1	Cell Transplantation 01/2018
1	Homologous Transplantation 10/2012
1	Nutritional Support (Artificial Feeding) 04/2009
1	Drug Therapy (Chemotherapy) 09/2008